NAD reviews "public speaking" supplement
This article was originally published in The Tan Sheet
Deephaven Nutraceuticals discontinues unsupported claims and testimonials for its Bravina dietary supplement in print and Web ads following a National Advertising Division review, according to an Aug. 18 case report. As part of its ongoing monitoring program with the Council for Responsible Nutrition, NAD reviewed claims for the supplement, including claims it is "designed and manufactured for sufferers of public speaking anxiety." The Council of Better Business Bureaus division found the claims were not supported by any studies on the supplement, and that the supplement's nine botanical ingredients, including motherwort and passionflower, have not been found to reduce anxiety specifically related to public speaking. NAD increased scrutiny of dietary supplements in 2007 in part because CRN asked the division to help regulate industry ads (1"The Tan Sheet" Sept. 25, 2006)
You may also be interested in...
CRN is committing nearly half a million dollars over a three year period to triple the annual number of dietary supplement cases reviewed by the Council of Better Business Bureaus' National Advertising Division (NAD)
Trial diversity is among the issues that stakeholders worry could hinder vaccine uptake.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.